X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (707) 707
index medicus (689) 689
male (479) 479
siderosis - etiology (335) 335
female (291) 291
adult (287) 287
middle aged (279) 279
magnetic resonance imaging (200) 200
clinical neurology (184) 184
superficial siderosis (181) 181
siderosis - complications (155) 155
aged (145) 145
siderosis - pathology (143) 143
siderosis (135) 135
siderosis - diagnosis (127) 127
abridged index medicus (118) 118
iron (95) 95
central-nervous-system (91) 91
iron - metabolism (88) 88
neurosciences (77) 77
diagnosis (75) 75
animals (72) 72
adolescent (71) 71
eye foreign bodies - complications (69) 69
surgery (69) 69
cerebral amyloid angiopathy (66) 66
child (62) 62
ophthalmology (58) 58
siderosis - metabolism (53) 53
diagnosis, differential (50) 50
subarachnoid hemorrhage (50) 50
hearing loss, sensorineural - etiology (49) 49
neurology (49) 49
retrospective studies (47) 47
aged, 80 and over (45) 45
hemorrhage (43) 43
transfusion reaction (41) 41
brain - pathology (40) 40
siderosis - physiopathology (40) 40
tomography, x-ray computed (40) 40
follow-up studies (39) 39
risk factors (39) 39
treatment outcome (39) 39
radiology, nuclear medicine & medical imaging (38) 38
eye foreign bodies - surgery (37) 37
stroke (37) 37
central nervous system (36) 36
central nervous system diseases - diagnosis (36) 36
cerebral amyloid angiopathy - complications (35) 35
hemosiderosis (35) 35
medicine, general & internal (35) 35
otorhinolaryngology (35) 35
medicine & public health (34) 34
siderosis - diagnostic imaging (34) 34
disease (33) 33
eye foreign bodies - diagnosis (33) 33
liver - metabolism (33) 33
liver - pathology (33) 33
mri (33) 33
hemosiderin (32) 32
pathology (32) 32
subarachnoid hemorrhage - complications (32) 32
ataxia (31) 31
cortical superficial siderosis (31) 31
pediatrics (31) 31
siderosis - drug therapy (31) 31
ferritin (30) 30
eye diseases - etiology (29) 29
hemosiderosis - etiology (29) 29
intracerebral hemorrhage (29) 29
prevalence (29) 29
siderosis - surgery (29) 29
central nervous system diseases - complications (28) 28
deferoxamine - therapeutic use (28) 28
ferritins - blood (28) 28
hemosiderosis - diagnosis (28) 28
infant, newborn (28) 28
iron - analysis (28) 28
magnetic resonance imaging - methods (28) 28
subarachnoid hemorrhage - etiology (28) 28
time factors (28) 28
central nervous system diseases - etiology (27) 27
child, preschool (27) 27
hemosiderin - metabolism (27) 27
iron overload (27) 27
neurosurgery (27) 27
hematology (26) 26
biopsy (25) 25
hemochromatosis (25) 25
hemosiderosis - complications (25) 25
iron - blood (25) 25
neuroimaging (25) 25
brain (24) 24
care and treatment (24) 24
neuroradiology (24) 24
rats (24) 24
visual acuity (24) 24
cataract - etiology (23) 23
cerebral hemorrhage - etiology (23) 23
patients (23) 23
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (655) 655
French (51) 51
German (41) 41
Italian (14) 14
Japanese (13) 13
Russian (12) 12
Spanish (10) 10
Polish (8) 8
Chinese (3) 3
Serbian (3) 3
Czech (2) 2
Finnish (2) 2
Hungarian (2) 2
Romanian (2) 2
Hebrew (1) 1
Icelandic (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


NERVENARZT, ISSN 0028-2804, 04/2019, Volume 90, Issue 4, pp. 423 - 441
Acute management as well as establishing the etiology of an intracerebral hemorrhage is still a challenge for clinicians. The location of the intracerebral... 
ANDEXANET ALPHA | Stroke | CEREBRAL AMYLOID ANGIOPATHY | Diagnostics | PSYCHIATRY | RIVAROXABAN | Anticoagulation | INTRACRANIAL HEMORRHAGE | CARE | CLINICAL NEUROLOGY | REVERSAL | IMPACT | Treatment | SUPERFICIAL SIDEROSIS | PROTHROMBIN COMPLEX CONCENTRATE | Bleeding cause
Journal Article
European Journal of Neurology, ISSN 1351-5101, 12/2011, Volume 18, Issue 12, pp. 1426 - 1428
Journal Article
Pediatric Blood & Cancer, ISSN 1545-5009, 10/2018, Volume 65, Issue 10, pp. e27285 - n/a
Journal Article
EUROPEAN JOURNAL OF NEUROLOGY, ISSN 1351-5101, 12/2011, Volume 18, Issue 12, pp. 1426 - 1428
Background and purpose: Although hypercoagulability-induced thromboembolism is generally accepted as cause of cerebral ischaemia in thalassemic patients,... 
atrial fibrillation | cardiac siderosis | ss-thalassemia major | dilative cardiomyopathy | thrombolysis | stroke | NEUROSCIENCES | CLINICAL NEUROLOGY
Journal Article
Journal Article
British Journal of Haematology, ISSN 0007-1048, 02/2010, Volume 148, Issue 3, pp. 466 - 475
Summary Cardiac and endocrine disorders are common sequelae of iron overload in transfused thalassaemia patients. Combined chelation with desferrioxamine (DFO)... 
iron overload | thalassaemia | endocrinopathy | cardiomyopathy | combined chelation | Endocrinopathy | Iron overload | Thalassaemia | Combined chelation | Cardiomyopathy | CARDIOVASCULAR MAGNETIC-RESONANCE | HEART-FAILURE | INSULIN SENSITIVITY | TRANSFUSION-DEPENDENT THALASSEMIA | GLUCOSE-METABOLISM | MYOCARDIAL SIDEROSIS | SUBCLINICAL THYROID-DYSFUNCTION | BETA-THALASSEMIA | HEMATOLOGY | NORMOGLYCEMIC PATIENTS | COMBINED THERAPY | Follow-Up Studies | Iron Overload - drug therapy | Humans | Thyroxine - administration & dosage | Endocrine System Diseases - etiology | Deferoxamine - therapeutic use | Male | beta-Thalassemia - complications | Deferoxamine - adverse effects | Cardiomyopathies - etiology | Iron Overload - blood | Young Adult | Ferritins - blood | Adult | Female | Drug Therapy, Combination | Child | Endocrine System Diseases - drug therapy | Cardiomyopathies - drug therapy | Iron Chelating Agents - therapeutic use | beta-Thalassemia - therapy | Drug Administration Schedule | Liver - metabolism | Hypothyroidism - etiology | Iron Chelating Agents - adverse effects | Transfusion Reaction | Iron Overload - complications | Adolescent | Hypothyroidism - drug therapy | Pyridones - therapeutic use | Blood Glucose - metabolism | Pyridones - adverse effects | Testosterone | Complications and side effects | Glucose metabolism | Cardiac patients | Thyroxine | Ferritin | Isoflurophate | Iron | Glucose | Hypothyroidism | Dextrose | Index Medicus
Journal Article
Neurology, ISSN 0028-3878, 08/2005, Volume 65, Issue 3, pp. 486 - 488
Journal Article
Journal Article
Journal of Neurology, ISSN 0340-5354, 12/2017, Volume 264, Issue 12, pp. 2413 - 2419
Journal Article
Journal Article
Journal of Cardiovascular Magnetic Resonance, ISSN 1097-6647, 2008, Volume 10, Issue 1, pp. 12 - 12
Background: In thalassemia major (TM), severe cardiac siderosis can be treated by continuous parenteral deferoxamine, but poor compliance, complications and... 
TISSUE IRON | CARDIAC & CARDIOVASCULAR SYSTEMS | CARDIOVASCULAR MAGNETIC-RESONANCE | DIASTOLIC FUNCTION | HEART-FAILURE | CA2+ CHANNELS | RANDOMIZED CONTROLLED-TRIAL | TREATED PATIENTS | IRON-OVERLOAD CARDIOMYOPATHY | BETA-THALASSEMIA | NATRIURETIC PEPTIDE | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Prospective Studies | Humans | Deferoxamine - therapeutic use | Male | Cardiomyopathies - etiology | Cardiomyopathies - physiopathology | Ferritins - blood | Liver - drug effects | Injections, Subcutaneous | Myocardium - metabolism | Cardiomyopathies - drug therapy | Iron Chelating Agents - therapeutic use | Administration, Oral | Liver - metabolism | Siderosis - etiology | beta-Thalassemia - physiopathology | Iron - metabolism | Iron Chelating Agents - adverse effects | Ventricular Dysfunction, Left - metabolism | beta-Thalassemia - drug therapy | Magnetic Resonance Imaging | Italy | beta-Thalassemia - metabolism | Siderosis - physiopathology | beta-Thalassemia - pathology | Siderosis - metabolism | beta-Thalassemia - complications | Deferoxamine - administration & dosage | Deferoxamine - adverse effects | Pyridones - administration & dosage | Adult | Female | Iron Chelating Agents - administration & dosage | Drug Therapy, Combination | Natriuretic Peptide, Brain - blood | Severity of Illness Index | Siderosis - drug therapy | Stroke Volume - drug effects | Ventricular Dysfunction, Left - etiology | Cardiomyopathies - pathology | Treatment Outcome | Ventricular Dysfunction, Left - physiopathology | Ventricular Dysfunction, Left - drug therapy | Siderosis - complications | Cardiomyopathies - metabolism | Cardiomyopathies - complications | Pyridones - therapeutic use | Siderosis - pathology | Pyridones - adverse effects | Prevention | Usage | Care and treatment | Magnetic resonance imaging | Cardiomyopathy | Thalassemia | Research | Diagnosis | Chelation therapy | Heart diseases | Index Medicus
Journal Article